Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NDFLP
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DCD133KDEL
|
|||||
| Synonyms |
DCD133KDEL; OXS 1650; OXS-1650
Click to Show/Hide
|
|||||
| Organization |
University of Minnesota; GT Biopharma, Inc.
|
|||||
| Drug Status |
Phase 1 (Terminated)
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
Undisclosed
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Prominin-1 (PROM1)
|
Antigen Info | ||||
| Payload Name |
Pseudomonas exotoxin PE38
|
Payload Info | ||||
| Therapeutic Target |
Eukaryotic elongation factor 2 (EEF2)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
